Galderma Group AG

Galderma Group AG is a global dermatology company dedicated to the research, development, and commercialization of innovative products and solutions for skin health. Established in 1981 and headquartered in Zug, Switzerland, its primary function is to address medical, aesthetic, and therapeutic needs across the dermatology sector. Galderma’s portfolio encompasses injectable aesthetics, dermatological skincare, and prescription treatments, featuring internationally recognized brands such as Cetaphil, Restylane, Dysport, Sculptra, Epiduo, and Differin. The company partners closely with healthcare professionals to deliver science-based solutions for conditions like acne, psoriasis, atopic dermatitis, rosacea, and skin aging. Galderma operates in over 100 countries, utilizing significant investment in research and development with dedicated sites spanning North America and Europe. As a pure-play dermatology leader, Galderma holds a unique position in the healthcare market, serving both clinical and consumer sectors, and consistently advancing the field through innovation and a strong commitment to skin science.